Overview of CMS Audit Updates
The Centers for Medicare and Medicaid Services (CMS) has released critical updates regarding its Medicare Advantage (MA) audit strategy, signaling renewed commitment to payment accuracy oversight despite recent legal setbacks. This development comes five months after a federal court decision significantly impacted the agency’s recovery methodology.
Recent Developments in Federal Oversight
Last week, CMS issued a comprehensive memo to MA plans outlining its intention to proceed with accelerated Risk Adjustment Data Validation (RADV) audits. The announcement represents the agency’s most detailed disclosure on audit procedures since September 2024, when the Northern District of Texas invalidated key provisions of the 2023 RADV final rule.
Understanding RADV Audits
What Are RADV Audits?
Risk Adjustment Data Validation audits serve as retrospective payment reviews designed to verify the accuracy of government reimbursements to insurance carriers participating in Medicare Advantage. These comprehensive examinations ensure that insurers receive appropriate compensation based on actual patient health needs rather than inflated diagnosis coding.
How the Audit Process Works
In standard RADV procedures, CMS requests MA plans submit medical documentation supporting diagnosis codes for selected member samples. This verification process aims to prevent overpayments resulting from unsupported or exaggerated health condition claims.
The Overpayment Crisis
Federal estimates suggest Medicare Advantage plans may be collecting approximately $17 billion annually in overpayments through unsupported diagnosis codes. The congressional advisory group MedPAC projects total overpayments could reach $76 billion this year—a staggering figure given Medicare’s declining financial reserves.
Legal Challenges and Agency Response
The 2023 Rule Controversy
The Biden administration’s 2023 final rule introduced extrapolation methodology, allowing regulators to audit small enrollee samples and project findings across entire plan populations. This approach promised to recover approximately $4.7 billion in additional overpayments over ten years.
Court Decision Impact
Humana, the nation’s second-largest MA carrier, successfully challenged the rule in federal court. Texas Judge Reed O’Connor vacated the final rule, citing regulatory failures to ensure payment parity between Medicare Advantage and traditional Medicare programs. This decision forced CMS to revert to older RADV methodologies, creating uncertainty around recent audit validity.
CMS Administrator’s Position
Despite legal obstacles, CMS Administrator Dr. Mehmet Oz maintains commitment to expediting audits covering payment years 2018 through 2024. “Strengthening oversight of MA payments is a top priority of this Administration,” a CMS spokesperson confirmed, emphasizing the agency’s dedication to comprehensive audit strategies ensuring payment accuracy.
Audit Timeline and Implementation
Current Audit Schedule
CMS initiated audits of 2019 reimbursements last summer, marking the first comprehensive review examining all eligible MA contracts rather than selective sampling. The agency anticipates beginning 2020 audits by month’s end, with future RADV audits scheduled quarterly.
Historical Context
Recoveries tied to audits from 2011 to 2013 are expected “soon,” according to agency statements. Notably, CMS hasn’t achieved significant RADV recovery since the 2007 payment year, despite mounting evidence of systematic overpayments.
Seven-Year Backlog Resolution
The accelerated timeline addresses a substantial seven-year RADV backlog. Moving forward, CMS plans publishing audit calendars allowing MA carriers adequate preparation time for compliance requirements.
Operational Changes and Improvements
Extended Submission Periods
Responding to plan concerns about administrative burden, regulators now provide five months instead of three for medical record submissions documenting member health needs. This extension acknowledges the significant coordination required between insurers and healthcare providers.
Reduced Documentation Requirements
CMS has lowered maximum medical record submission limits, attempting to ease administrative loads on both requesting plans and record-providing practitioners. Additionally, audits will utilize smaller samples adjusted proportionally to individual plan sizes.
Transparency Enhancements
The agency committed to improved transparency throughout audit processes, including advance calendar publication and clearer communication protocols with audited plans.
Financial Implications for Medicare
Medicare Trust Fund Concerns
With Medicare reserves dwindling, recovering inappropriate overpayments becomes increasingly critical. The projected $76 billion in annual overpayments represents substantial resources that could strengthen program sustainability.
2027 Payment Rule Proposal
The Trump administration recently proposed significant MA risk adjustment overhaul in the draft 2027 payment rule. This provision would exclude member diagnoses unconnected to actual medical treatment from risk adjustment calculations, eliminating financial incentives for chart mining unrelated conditions.
Future Direction and Technology Integration
Artificial Intelligence Implementation
CMS plans deploying new AI-backed technology as medical coding support tools. However, the agency emphasizes that all overpayment determinations will remain under human decision-making authority, ensuring accountability and accuracy.
Staffing Considerations
While specific hiring numbers remain undisclosed, CMS evaluates operational and resource needs, “including potential avenues to augment medical coding capacity,” according to agency spokespersons. Discussions regarding additional coder support scope and sourcing continue.
Political Landscape Shift
The current administration demonstrates unexpectedly robust commitment to curbing MA overpayments. This represents notable departure from the first Trump administration, when MA payers experienced minimal oversight contributing to lucrative margins. Rising consumer concerns about healthcare affordability and plan costs have pressured Washington toward stronger insurer accountability measures.
